The 2 Wall Street analysts covering ChronoScale Holdings Corp. hold a median 12-month price target of $29 — +136.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 4 of 100 as at 4 Nov 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores ChronoScale Holdings Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Momentum (77): The shares have been drifting up relative to others.
Issuance (2): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on CHRN, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +136.5% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 18 Sept 2026 | Northland Capital Markets | Initiates | Outperform | $32 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The model tests each one against its peers. 1 pass every test this week.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, ChronoScale Holdings Corp. returned +134.9% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 98% of US stocks
Cheaper than 9% of US stocks
Cheaper than 8% of US stocks
Cheaper than 1% of US stocks
Higher than 95% of US stocks
Higher than 16% of US stocks
Higher than 7% of US stocks
Higher than 28% of US stocks
Higher than 22% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
ChronoScale Holdings Corp. has a market value of $2.0B and an enterprise value of $2.1B.
Trailing P/E: −32.5×; forward P/E: 66.8× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
ChronoScale Holdings Corp. employs 84 people.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own ChronoScale Holdings Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
ChronoScale Holdings reported financial results for the fiscal first quarter ended August 31, 2026.
Why it matters — The release marks an update on CHRN’s recent quarterly financial performance, though the excerpt provides no specific results.
Wandercraft announced it has acquired Ekso Bionics, Inc. from a subsidiary of ChronoScale Holdings Corporation, combining two leaders in robotic mobility. The announcement was made from New York and San Rafael, California.
Why it matters — A CHRN watcher would care because the announcement confirms the divestiture of Ekso Bionics from a ChronoScale Holdings subsidiary as part of a published corporate transaction.
ChronoScale Holdings announced an expanded agreement with an existing AI infrastructure customer and a new agreement with an additional customer, which together increase its contracted deployment pipeline and are expected to bring annualized revenue run rate to $1 billion by calendar Q3 2027. The company also completed its previously disclosed sale of the Ekso Bionics business unit.
Why it matters — The expanded and new customer agreements project a $1 billion annualized revenue run rate by calendar Q3 2027 and strengthen ChronoScale's contracted AI infrastructure revenues, while the completed divestiture of Ekso Bionics simplifies its business focus.
ChronoScale announced a partnership with Microsoft for a 50-megawatt AI compute deployment in North America. The company, which positions itself as an accelerated compute platform for demanding AI workloads, disclosed the plan on Aug. 27, 2026.
Why it matters — A 50 MW AI compute deployment with Microsoft represents a major infrastructure commitment that could expand ChronoScale's compute capacity and market presence in North America.
Nutanix and ChronoScale announced a strategic partnership to integrate their platforms, enabling enterprises to access ChronoScale GPU-as-a-Service, pre-paid inference tokens via ChronoScale Token Factory, and a locally-deployed ChronoScale Foundry for agentic AI workflows. The collaboration includes go-to-market, joint solution development, technical integration, and customer engagement programs, with ChronoScale leveraging Nutanix's Agentic AI software solution for neoclouds to deliver accelerated compute and AI services.
Why it matters — A CHRN watcher would note this partnership broadens ChronoScale's distribution and customer reach through collaboration with an established enterprise platform provider.
The 2 Wall Street analysts covering ChronoScale Holdings Corp. have a median 12-month price target of $29, with estimates ranging from $25 to $32. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 2 analysts covering ChronoScale Holdings Corp., 2 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks ChronoScale Holdings Corp. 4 out of 100 across roughly 4,600 US stocks as at 4 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 4 Nov 2026, ChronoScale Holdings Corp. ranks 4 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (77 of 100).
No one can know that. What the data says: the median 12-month target from 2 analysts implies +136.5% from the last close, and Ticker Nerd's factor model ranks ChronoScale Holdings Corp. 4 out of 100 as at 4 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering ChronoScale Holdings Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CHRN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $25 to $32 over the next 12 months.
ChronoScale Holdings Corp. returned +134.9% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
ChronoScale Holdings Corporation Common Stock is the equity security of ChronoScale Holdings Corporation, a Dallas-based technology company focused on GPU-accelerated cloud infrastructure for artificial intelligence workloads. The company designs and operates dedicated compute environments that support large-scale AI training, inference, machine learning, and high-performance computing applications.
The most recent item we track (GlobeNewsWire, 15 Oct 2026): "ChronoScale Reports Fiscal First Quarter 2027 Results". ChronoScale Holdings reported financial results for the fiscal first quarter ended August 31, 2026.
ChronoScale Holdings Corporation Common Stock is the equity security of ChronoScale Holdings Corporation, a Dallas-based technology company focused on GPU-accelerated cloud infrastructure for artificial intelligence workloads. The company designs and operates dedicated compute environments that support large-scale AI training, inference, machine learning, and high-performance computing applications. Its current business centers on providing scalable cloud capacity and specialized computing solutions to organizations that need consistent, performance-oriented infrastructure for demanding data-intensive tasks. ChronoScale Holdings also offers access to graphics processing units and related compute services, positioning itself within the broader AI infrastructure market where reliable processing power is a core requirement. The stock represents ownership in a company whose operations are concentrated in modern cloud and AI compute services rather than consumer-facing products.
CEO Ms. Ying Cenly Chen · 84 employees · United States · https://chronoscale.com
